JPS5748916A - Tumor inhibiting substances and use - Google Patents

Tumor inhibiting substances and use

Info

Publication number
JPS5748916A
JPS5748916A JP56107228A JP10722881A JPS5748916A JP S5748916 A JPS5748916 A JP S5748916A JP 56107228 A JP56107228 A JP 56107228A JP 10722881 A JP10722881 A JP 10722881A JP S5748916 A JPS5748916 A JP S5748916A
Authority
JP
Japan
Prior art keywords
inhibiting substances
tumor inhibiting
tumor
substances
tumour
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP56107228A
Other languages
English (en)
Inventor
Deiitaa Buorufu Geruharuto
Beemaa Buruuno
Biiaringu Roberuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS5748916A publication Critical patent/JPS5748916A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08—Processes
    • C08G18/0804—Manufacture of polymers containing ionic or ionogenic groups
    • C08G18/0819—Manufacture of polymers containing ionic or ionogenic groups containing anionic or anionogenic groups
    • C08G18/0828—Manufacture of polymers containing ionic or ionogenic groups containing anionic or anionogenic groups containing sulfonate groups or groups forming them
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/48—Polyethers
    • C08G18/4833—Polyethers containing oxyethylene units
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/48—Polyethers
    • C08G18/50—Polyethers having heteroatoms other than oxygen
    • C08G18/5072—Polyethers having heteroatoms other than oxygen containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/83—Chemically modified polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/83—Chemically modified polymers
    • C08G18/831—Chemically modified polymers by oxygen-containing compounds inclusive of carbonic acid halogenides, carboxylic acid halogenides and epoxy halides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP56107228A 1980-07-12 1981-07-10 Tumor inhibiting substances and use Pending JPS5748916A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803026575 DE3026575A1 (de) 1980-07-12 1980-07-12 Antitumoral wirkende mittel

Publications (1)

Publication Number Publication Date
JPS5748916A true JPS5748916A (en) 1982-03-20

Family

ID=6107113

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56107228A Pending JPS5748916A (en) 1980-07-12 1981-07-10 Tumor inhibiting substances and use

Country Status (6)

Country Link
EP (1) EP0043974B1 (ja)
JP (1) JPS5748916A (ja)
AT (1) ATE8014T1 (ja)
AU (1) AU543561B2 (ja)
CA (1) CA1177402A (ja)
DE (2) DE3026575A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989007117A1 (en) * 1988-02-01 1989-08-10 Tyndale Plains-Hunter, Ltd. Thermally reversible polyurethane hydrogels and cosmetic, biological and medical uses
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
DE4109668A1 (de) * 1991-03-23 1992-09-24 Bayer Ag Isocyanatfreie oligomere urethanharze
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
DE4225045A1 (de) * 1992-07-29 1994-02-03 Basf Ag Verwendung von wasserlöslichen oder in Wasser dispergierbaren Polyurethanen als Hilfsmittel in kosmetischen und pharmazeutischen Zubereitungen und Polyurethane, die Polymilchsäurepolyole einpolymerisiert enthalten
CA2142110A1 (en) * 1992-08-19 1994-03-03 Paul S. Wright Antiangiogenic oligomers
JPH0753663A (ja) * 1993-07-30 1995-02-28 Takiron Co Ltd 経皮吸収製剤用基剤ポリマー
US5384119A (en) * 1993-08-12 1995-01-24 Merrell Dow Pharmaceuticals Inc. Method of preventing neutrophil mediated connective tissue damage
FR2907678B1 (fr) 2006-10-25 2012-10-26 Oreal Composition de coloration des fibres keratiniques comprenant un copolymere bloc polysiloxane/polyuree

Also Published As

Publication number Publication date
EP0043974A3 (en) 1982-01-27
EP0043974B1 (de) 1984-06-20
AU543561B2 (en) 1985-04-26
ATE8014T1 (de) 1984-07-15
AU7245381A (en) 1982-01-21
DE3164296D1 (en) 1984-07-26
CA1177402A (en) 1984-11-06
DE3026575A1 (de) 1982-02-04
EP0043974A2 (de) 1982-01-20

Similar Documents

Publication Publication Date Title
EG14737A (en) Alfa-alkyl-alfa-phenyl-2-n,1,2,4-triazole-1-ethanols and their use as fungicides
PH18938A (en) 2-substituted phenyl-4,5,6,7-tetrahydro-2h-indazoles and their use
PH30904A (en) Antimicrobial composition containing type II endoglycosidase and antimicrobial agent.
EP0035800A3 (en) Soil treating agent
GB2087388B (en) 4,5-polymethylene-4-isothiazoline-3-ones and their use as bactericides and fungicides
IL61930A (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol and pharmaceutical compositions containing it
GB2068190B (en) Class "b" type amplifier
JPS5748916A (en) Tumor inhibiting substances and use
EP0366753A4 (en) N-ALKOXYALKYLAMID AND COSMETIC TREATMENT COMPOSITIONS.
IL58526A0 (en) 24.24-difluoro-1 .25-dihydroxycholecalciferol and pharmaceutical compositions containing it
GR78135B (ja)
JPS5758675A (en) Herbicidal 3-benzylsulfonyl-1-diethylcarbamoyl- 1,2,4-triazole, herbicidal composition containing same and use
IL62637A0 (en) Trisubstituted cyanoguanidines,their preparation and their use as fungicides
IL91851A0 (en) Antimicrobial compositions containing 2,2-dibromo-2-nitroethanol and methods for killing microorganisms utilizing the same
EG18727A (en) Anilinophenylthioureas, anilinophenylisothioureas, anilinophenylcabodimides, compositions containing them, and the use in pest control
JPS56139435A (en) 3,3-dimethyl-1-phenoxy-butan-2-ol and manufacture
IL62395A0 (en) 4,n,n-dimethylcarbamoyloxy-5-methyl-pyrimidines,their production and their use as pesticides
GB2104061B (en) 2, 3-dihydropyrans and methods for combatting insects therewith
JPS57140742A (en) 1,8-dihydroxy-9-anthrone adduct and manufacture
IL68156A (en) N-(6-(n-methoxy-n-alkyl)amino-4-alkoxy-1,3,5-triazin-2-yl-aminocarbonyl)-benzenesulfonamides and herbicidal compositions containing them
DE3169413D1 (en) Medicament and cosmetic for external application
IL70236A (en) N,n-dialkyl-2-(4'-substituted-1'-naphthoxy)-propionamides and their use as herbicides
JPS57108036A (en) 2,2-dimethylcyclobutanones and manufacture
ZA814885B (en) 2-iodoacetylimino-3-methyl-5-trifluoromethyl-1,3,4-thiadiazol-4-ine and use as a fungicide
Fygetakis The efficacy of cue-controlled relaxation beyond nonspecific treatment effects